Publications by authors named "Qiaoping Xu"

Claim this Profile
L
Long non-coding RNA in hepatocellular carcinoma: mechanistic insights and therapeutic perspectives.
Kexin Yu, Yuanxiang Jin, Yidong Zhou, Qiaoping Xu

Cell Oncol (Dordr)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of sugemalimab plus chemotherapy as first-line therapy in advanced gastric cancer and gastroesophageal junction cancer.
Jiaming Zhu, Zhengxiong Li, Qiaoping Xu

Ann Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to Corcept's retraction request on manuscript of "Relacorilant plus nab-paclitaxel for recurrent, platinum-resistant ovarian cancer: a cost-effectiveness study".
Qiaoping Xu

J Gynecol Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting cuproptosis for treatment and prognostic assessment in endometrial cancer.
Jie Yu, Huan Shi, Jingxia Zhang, Weiyan Shan, Qiaoping Xu

Cancer Cell Int· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performance comparison of Mindray EH-2090 Urinalysis analyzers and Sysmex UF-5000.
Juan Chen, Chen Zhang, Qiaoping Xu, Zhicheng Wu

Scand J Clin Lab Invest· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A cost-effectiveness comparison between immunotherapy combination regimens and sunitinib for advanced renal cell carcinoma in the USA and China.
Haojie Ying, Fei Tong, Yidong Zhou, Binzhe Zhou, Kai Qiao, Qiaoping Xu

Ther Adv Med Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exosomal noncoding RNAs in renal cell carcinoma: Mechanisms, roles, and therapeutic potential.
Jiaming Zhu, Ye Ding, Qiaoping Xu

Crit Rev Oncol Hematol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of talazoparib plus enzalutamide as first-line therapy in metastatic castration-resistant prostate cancer.
Jiaming Zhu, Zhengxiong Li, Ye Ding, Qiaoping Xu

Ther Adv Med Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Pathophysiological Role of Mitochondrial Oxidative Stress in Rheumatic Diseases.
Zhao Ma, Qiaoping Xu, Xinchang Xu

J Inflamm Res· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of m6A RNA methylation regulators in pancreatic cancer: interactions and potential implications.
Li Liao, Xiaoqiang Xu, Yu Cao, Kezhong Tang, Qiaoping Xu

Cancer Cell Int· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relacorilant plus nab-paclitaxel for recurrent, platinum-resistant ovarian cancer: a cost-effectiveness study.
Yidong Zhou, Fei Tong, Bowen Jin, Junjie Pan, Ning Ren, Qiaoping Xu

J Gynecol Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dexamethasone Promotes Autophagy Dependent Ferroptosis of Placental Trophoblast Cells Through GRα.
Junlei Lu, Xinyun Huang, Yuan Xu, Qiaoping Xu, Hongkai Shang

J Cell Mol Med· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The emerging role of glycolysis and immune evasion in ovarian cancer.
Bowen Jin, Zehua Miao, Junjie Pan, Zhen Zhang, Yibei Yang, Qiaoping Xu

Cancer Cell Int· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cuproptosis: a promising new target for breast cancer therapy.
Qianqian Jiang, Fei Tong, Yun Xu, Cheng Liu, Qiaoping Xu

Cancer Cell Int· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Ferroptosis: a new promising target for hepatocellular carcinoma therapy.
Qiaoping Xu, Lanqi Ren, Ning Ren, Yibei Yang, Junjie Pan

Mol Cell Biochem· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functions and mechanisms of RNA mA regulators in breast cancer (Review).
Yibei Yang, Feng Gao, Lanqi Ren, Ning Ren, Junjie Pan, Qiaoping Xu

Int J Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of N‑methyladenosine in the pathogenesis, diagnosis and treatment of prostate cancer (Review).
Junjie Pan, Fei Tong, Ning Ren, Lanqi Ren, Yibei Yang, Qiaoping Xu

Oncol Rep· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of talazoparib for patients with germline BRCA1/2 mutated HER2-negative advanced breast cancer in China and the US.
Junjie Pan, Ning Ren, Lanqi Ren, YiBei Yang, Qiaoping Xu

Sci Rep· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
4
46, XX disorder of sexual development associated with mixed germ cell tumor of the prostate: a rare case report.
Changrong Wang, Jiangli Du, Xueping Xiang, Yuyong Wang, Jingjing Xiang, Qiaoping Xu

BMC Urol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performance analysis of urine formed element analyzer EH-2090 was found to have good accuracy in detecting RBCs and WBCs when compared to manual microscopic.
Lixia Bai, Qiaoping Xu, Zhicheng Wu

Transl Androl Urol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RNA m6A methylation regulators in liver cancer.
Qiaoping Xu, Ning Ren, Lanqi Ren, Yibei Yang, Junjie Pan

Cancer Cell Int· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Homologous recombination deficiency serves as a prognostic biomarker in clear cell renal cell carcinoma.
Liping He, Feng Gao, Jingyu Zhu, Qiaoping Xu, Qiqi Yu

Exp Ther Med· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic evaluation of third-line neratinib plus capecitabine versus lapatinib plus capecitabine with HER2+ metastatic breast cancer.
Lanqi Ren, Ning Ren, Yu Zheng, Yibei Yang, Qiaoping Xu

Front Oncol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel DNA methylation signature to improve survival prediction of progression-free survival for testicular germ cell tumors.
Feng Gao, Qiaoping Xu, Yingjun Jiang, Bingjun Lu

Sci Rep· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exosomes derived from myeloid-derived suppressor cells facilitate castration-resistant prostate cancer progression via S100A9/circMID1/miR-506-3p/MID1.
Feng Gao, Qiaoping Xu, Zhe Tang, Nan Zhang, Yasheng Huang

J Transl Med· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis